Cancer Therapy

Radiology Life • February 2017

/ FEBRUARY 2017 THINKSTOCK 10 | ADVANCE FOR RADIOLOGY LiFE | CANCER THERAPY C A N C E R T H E R A P Y The Benefits of Personalized Criteria The key to risk stratification in papillary thyroid cancer   By Paul Walfish, CM OOnt In 2016, an estimated 62,000 people in the U.S. were diagnosed with thyroid cancer. In current standard of care, a significant percentage of diagnosed patients are treated with thyroidectomy — either partial or total removal of the thyroid gland. Following the procedure, patients are unable to produce the thyroid hormone naturally. They require treatment with thyroid hormone replacement therapy for the rest of their lives to help maintain target levels of thyroid hormone. In addition, after a thyroidectomy many patients are treated with remnant ablation involving administration of radioactive iodine (RAI) to identify and eliminate remaining thyroid cells including cancer cells.


Radiology Life • February 2017
To see the actual publication please follow the link above